PL2231627T3 - Nowy sposób syntezy moguisteiny - Google Patents

Nowy sposób syntezy moguisteiny

Info

Publication number
PL2231627T3
PL2231627T3 PL08857548T PL08857548T PL2231627T3 PL 2231627 T3 PL2231627 T3 PL 2231627T3 PL 08857548 T PL08857548 T PL 08857548T PL 08857548 T PL08857548 T PL 08857548T PL 2231627 T3 PL2231627 T3 PL 2231627T3
Authority
PL
Poland
Prior art keywords
moguisteine
synthesis
methoxyphenoxy
methyl
new process
Prior art date
Application number
PL08857548T
Other languages
English (en)
Inventor
Enrico Vigano'
Massimiliano Arrighi
Renato Molteni
Simona Lanfranconi
Ernesto Landonio
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of PL2231627T3 publication Critical patent/PL2231627T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PL08857548T 2007-12-03 2008-12-02 Nowy sposób syntezy moguisteiny PL2231627T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07425770A EP2070915A1 (en) 2007-12-03 2007-12-03 New process for the synthesis of moguisteine
EP08857548A EP2231627B1 (en) 2007-12-03 2008-12-02 New process for the synthesis of moguisteine
PCT/EP2008/066591 WO2009071528A2 (en) 2007-12-03 2008-12-02 New process for the synthesis of moguisteine

Publications (1)

Publication Number Publication Date
PL2231627T3 true PL2231627T3 (pl) 2011-11-30

Family

ID=39450286

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08857548T PL2231627T3 (pl) 2007-12-03 2008-12-02 Nowy sposób syntezy moguisteiny

Country Status (12)

Country Link
EP (2) EP2070915A1 (pl)
KR (1) KR20110086503A (pl)
CN (1) CN101883761B (pl)
AT (1) ATE511505T1 (pl)
CY (1) CY1112328T1 (pl)
ES (1) ES2367466T3 (pl)
PL (1) PL2231627T3 (pl)
PT (1) PT2231627E (pl)
RS (1) RS51931B (pl)
RU (1) RU2492165C2 (pl)
SI (1) SI2231627T1 (pl)
WO (1) WO2009071528A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102653527A (zh) * 2011-12-22 2012-09-05 东莞达信生物技术有限公司 一种莫吉司坦合成工艺
CN105601584A (zh) * 2013-01-06 2016-05-25 天津市汉康医药生物技术有限公司 噻唑烷衍生物、其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
IT1216119B (it) * 1988-03-17 1990-02-22 Boehringer Biochemia Srl Beta_carbonil_carbossiamidi di 1,3_tiazolidine.
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Also Published As

Publication number Publication date
RU2492165C2 (ru) 2013-09-10
CN101883761A (zh) 2010-11-10
CY1112328T1 (el) 2015-12-09
ES2367466T3 (es) 2011-11-03
EP2070915A1 (en) 2009-06-17
KR20110086503A (ko) 2011-07-28
WO2009071528A3 (en) 2009-08-13
EP2231627A2 (en) 2010-09-29
ATE511505T1 (de) 2011-06-15
RU2010127348A (ru) 2012-01-10
PT2231627E (pt) 2011-09-13
CN101883761B (zh) 2013-03-27
WO2009071528A2 (en) 2009-06-11
SI2231627T1 (sl) 2011-10-28
EP2231627B1 (en) 2011-06-01
RS51931B (en) 2012-02-29

Similar Documents

Publication Publication Date Title
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
ZA201007977B (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
FR2938536B1 (fr) Procede de fabrication d'un methacrylate de methyle derive de la biomasse
NZ610104A (en) Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
WO2011015522A3 (en) Process for the manufacture of pharmaceutically active compounds
EA200870262A1 (ru) Способ получения оптических активных хиральных аминов
EA200970172A1 (ru) Пролекарство соединения амида коричной кислоты
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
WO2010088455A3 (en) Cromolyn derivatives and related methods of imaging and treatment
SG170729A1 (en) Processes and intermediates for preparing steric compounds
FR2940801B1 (fr) Procede de fabrication d'un methacrylate de methyle derive de la biomasse
IL190551A0 (en) Novel process for the preparation of acid chlorides
HK1126756A1 (en) Process for preparation of hiv protease inhibitors
MA29464B1 (fr) Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues
WO2009134531A3 (en) Total synthesis of salinosporamide a and analogs thereof
UA102220C2 (ru) Способ синтеза агомелатина
WO2007117591A3 (en) Total synthesis of salinosporamide a and analogs thereof
WO2008126943A3 (en) Method for manufacturing neuraminic acid derivatives
PL2183201T3 (pl) Sposób rozdziału zopiklonu i związki pośrednie
SI2231627T1 (sl) Nov postopek za sintezo moguisteina
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
NO20091261L (no) Framgangsmate for framstilling av pleuromutiliner
WO2015022702A3 (en) Process for preparation of 4,5-dimethoxybenzene derivatives and use in the synthesis of ivabradine and salts thereof